FDA Import Refusal UPS-4849375-3/2/2 — Titolare A.I.C.: Ravizza Farmaceutici Spa
The FDA refused shipment UPS-4849375-3/2/2 from Titolare A.I.C.: Ravizza Farmaceutici Spa (Italy) on Jan 19, 2016. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Jan 19, 2016
- Country
- Italy
- Product Category
- Drugs and Biologics
- Product Code
- 62GAY18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
- Charges
- 75